Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.
The 52 Week Low is $71.65 set on Tue, Nov 3, 2020.
The 52 Week High is $90.79 set on Thu, Jan 7, 2021.
The All-Time High is $151.75 set on Mon, Jul 20, 2015. The current price, $79.30, is 48% below the All Time High.
BioMarin Pharmaceutical trades on the NASDAQ. BMRN's market cap is 14.3 Billion.
BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin's Roctavian (hemophilia A gene therapy) and vosoritide (treatment for achondroplasia) are poised to potentially launch in the 2021-22 timeframe.